The FDA recommends healthcare professionals co-prescribe the opioid overdose reversal drug with all opioid prescriptions.
The FDA recommends healthcare professionals co-prescribe the opioid overdose reversal drug with all opioid prescriptions.
A study of 41,000 adults finds that only treatment with buprenorphine or methadone reduced risk of overdose.
The guideline covers a wide range of relevant topics, including pain, dosing, dangerous co-prescribing, comorbidities, and more.
Four research sites will test proven opioid prevention and treatment interventions, hoping to reduce overdose deaths by 40% over three years.
The reSET-O app uses cognitive behavioral therapy techniques to assist patients engaged in medication-assisted therapy for opioid dependence.
